<DOC>
	<DOCNO>NCT02873390</DOCNO>
	<brief_summary>To evaluate safety effectiveness cell therapy use herinCAR-PD1 cell treat advance cancer . Individuals great equal 18 year age less equal 70 year age diagnose relapsed refractory cancer respond relapsed standard treatment .</brief_summary>
	<brief_title>PD-1 Antibody Expressing CAR-T Cells EGFR Family Member Positive Advanced Solid Tumor</brief_title>
	<detailed_description>A total 20 patient may enrol period 1-2 year .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>1 . Age 18~80 year old , male female ; 2 . Life expectancy≥6 month ; 3 . ECOG score : 02 ; 4 . Advanced Solid Tumor diagnose histology cytology ; 5 . Enough venous channel , contraindication separation collection white blood cell ; 6 . Immunohistochemistry RTPCR technology use determine positive EGFR family ( include EGFR , HER2 , HER4 ) EGFRVIII、IGF1R protein . At least one protein express immunohistochemical tumor tissue less grade 2 2+ score . The level protein define follow : ( accord cell stain ) : grade 0 : without stain ; grade 1 : 125 % ; grade 2 : 2650 % grade 3 : 51100 % ; ( According intensity ) : negative ; 1+ ; 2+ 3+ ; 7 . Laboratory examination : white blood cell≥3 x 10*9/L , blood platelet count≥60 x10*9/L , hemoglobin≥85g/L ; lymphocyte ≥0.7×109/L , total bilirubin le 2.5 time normal level ; ALT AST less 2.5 time normal level ; serum creatinine less 1.5 time normal level； 8 . Signed inform consent； 9 . Women childbearing age must evidence negative pregnancy test willing practice birth control 4 month follow cell transfusion . 10 . Disease progression current treatment invalid . 11 . The treatment effect ideal receive 2 line therapy least willing join clinical trial 1 . Expected Overall survival ＜ 6 month ; 2 . Patients uncontrolled hypertension , unstable coronary disease ( uncontrolled arrhythmia , unstable angina , decompensated congestive heart failure ( &gt; Class II , NYHA ) , myocardial infarction within 6 month . 3 . Abnormal lung function : FEV ( forced expiratory volume ) &lt; 30 % prediction , DLCO ( diffuse capacity lung carbon monoxide ) &lt; 30 % prediction , blood oxygen saturation &lt; 90 % ; 4 . Other serious disease : nervous , mental disorder , immune regulatory disease , metabolic disease , infectious disease , etc ; 5 . Unable unwilling provide inform consent , fail comply test requirement . 6 . Uncontrolled active infection . 7 . Serious chronic disease critical organ kidney liver . Kidney function CKD stage I , liver function le Child Pugh class B ; 8 . Longterm use use immunosuppressive drug autoimmune diseases 9 . Glucocorticoid need long term . 10 . Currently ( within 30 day ) enrol another clinical trial . 11 . Pregnancy breastfeed woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>PD-1 Antibody</keyword>
	<keyword>CAR-T Cells</keyword>
	<keyword>EGFR family</keyword>
	<keyword>Advanced Malignancies</keyword>
</DOC>